DOI: 10.1128/mBio.00976-20
Article Information
PubMed
Published By
History
- Received April 21, 2020
- Accepted June 11, 2020
- Published online July 14, 2020.
Copyright & Usage
Copyright © 2020 Wuerth et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Tetsuro Ikegami, Invited Editor, The University of Texas Medical Branch at Galveston
- Thomas E. Morrison, Editor, University of Colorado School of Medicine
Author Information
- Jennifer Deborah Wuertha,b,c,
- Matthias Habjand,
- Markus Kainulainenb,
- Besim Berishaa,
- Damien Berthelootc,
- Giulio Superti-Furgae,f,
- Andreas Pichlmaird,g,h,
- Friedemann Webera,b,h
- aInstitute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Giessen, Germany
- bInstitute for Virology, Philipps-University Marburg, Marburg, Germany
- cInstitute of Innate Immunity, University of Bonn, Bonn, Germany
- dInnate Immunity Laboratory, Max-Planck Institute of Biochemistry, Munich, Germany
- eCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
- fCenter for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
- gInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany
- hGerman Center for Infection Research (DZIF), partner sites Giessen and Munich, Germany
- Address correspondence to Friedemann Weber, friedemann.weber{at}vetmed.uni-giessen.de.
Citation Wuerth JD, Habjan M, Kainulainen M, Berisha B, Bertheloot D, Superti-Furga G, Pichlmair A, Weber F. 2020. eIF2B as a target for viral evasion of PKR-mediated translation inhibition. mBio 11:e00976-20. https://doi.org/10.1128/mBio.00976-20.
